626 related articles for article (PubMed ID: 18477354)
1. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease.
Gisbert JP; Gomollón F
Am J Gastroenterol; 2008 May; 103(5):1299-307. PubMed ID: 18477354
[TBL] [Abstract][Full Text] [Related]
2. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial.
Kulnigg S; Stoinov S; Simanenkov V; Dudar LV; Karnafel W; Garcia LC; Sambuelli AM; D'Haens G; Gasche C
Am J Gastroenterol; 2008 May; 103(5):1182-92. PubMed ID: 18371137
[TBL] [Abstract][Full Text] [Related]
3. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
[TBL] [Abstract][Full Text] [Related]
4. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia.
Gasche C; Waldhoer T; Feichtenschlager T; Male C; Mayer A; Mittermaier C; Petritsch W;
Am J Gastroenterol; 2001 Aug; 96(8):2382-7. PubMed ID: 11513178
[TBL] [Abstract][Full Text] [Related]
5. Iron treatment and inflammatory bowel disease: what happens in real practice?
Lugg S; Beal F; Nightingale P; Bhala N; Iqbal T
J Crohns Colitis; 2014 Aug; 8(8):876-80. PubMed ID: 24486177
[TBL] [Abstract][Full Text] [Related]
6. Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease.
Voudoukis E; Karmiris K; Oustamanolakis P; Theodoropoulou A; Sfiridaki A; Paspatis GA; Koutroubakis IE
Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1212-6. PubMed ID: 23839158
[TBL] [Abstract][Full Text] [Related]
7. Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease.
Erichsen K; Ulvik RJ; Nysaeter G; Johansen J; Ostborg J; Berstad A; Berge RK; Hausken T
Scand J Gastroenterol; 2005 Sep; 40(9):1058-65. PubMed ID: 16165718
[TBL] [Abstract][Full Text] [Related]
8. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement.
Gisbert JP; Bermejo F; Pajares R; Pérez-Calle JL; Rodríguez M; Algaba A; Mancenido N; de la Morena F; Carneros JA; McNicholl AG; González-Lama Y; Maté J
Inflamm Bowel Dis; 2009 Oct; 15(10):1485-91. PubMed ID: 19408339
[TBL] [Abstract][Full Text] [Related]
9. Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD.
Lee T; Clavel T; Smirnov K; Schmidt A; Lagkouvardos I; Walker A; Lucio M; Michalke B; Schmitt-Kopplin P; Fedorak R; Haller D
Gut; 2017 May; 66(5):863-871. PubMed ID: 26848182
[TBL] [Abstract][Full Text] [Related]
10. [Pathophysiological-based diagnosis and therapy of iron-deficient anaemia in inflammatory bowel disease].
Stein JM; Hartmann F; Cordes HJ; Dignass AU
Z Gastroenterol; 2009 Feb; 47(2):228-36. PubMed ID: 19197827
[TBL] [Abstract][Full Text] [Related]
11. Caring for the renal failure patient: optimizing iron therapy.
Folkert VW; Javier AM; O'Mara NB
Nephrol Nurs J; 2002 Dec; 29(6):586-93; quiz 594-5. PubMed ID: 12596608
[TBL] [Abstract][Full Text] [Related]
12. Intravenous iron therapy in renal failure: friend and foe?
Afzali B; Goldsmith DJ
J Nephrol; 2004; 17(4):487-95. PubMed ID: 15372409
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis and management of iron deficiency anemia: emerging role of celiac disease, helicobacter pylori, and autoimmune gastritis.
Hershko C; Skikne B
Semin Hematol; 2009 Oct; 46(4):339-50. PubMed ID: 19786202
[TBL] [Abstract][Full Text] [Related]
14. [Risk of development of clinical and pathogenetic features of anemia on the background of basic therapy of inflammatory bowel disease].
Noskova KK; Lishchinskaia AA; Parfenov AI; Kniazev OV; Varvanina GG; Drozdov VN
Eksp Klin Gastroenterol; 2011; (10):12-7. PubMed ID: 22629693
[TBL] [Abstract][Full Text] [Related]
15. Current practice in the diagnosis and management of IBD-associated anaemia and iron deficiency in Germany: the German AnaemIBD Study.
Blumenstein I; Dignass A; Vollmer S; Klemm W; Weber-Mangal S; Stein J
J Crohns Colitis; 2014 Oct; 8(10):1308-14. PubMed ID: 24721157
[TBL] [Abstract][Full Text] [Related]
16. [Management of renal anemia in patients with chronic kidney disease: the role of the general practitioner].
Ruedin P; Dickenmann M; Martin PY; Wüthrich RP
Rev Med Suisse; 2012 Jan; 8(323):70-3. PubMed ID: 22303745
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of anaemia in patients with inflammatory bowel diseases in North-Eastern Romania.
Dumitrescu G; Dranga M; Pintilie IA; Nedelciuc O; Mihai C; Prelipcean CC
Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):968-74. PubMed ID: 23700874
[TBL] [Abstract][Full Text] [Related]
18. The diagnosis and treatment of iron deficiency and its potential relationship to hair loss.
Trost LB; Bergfeld WF; Calogeras E
J Am Acad Dermatol; 2006 May; 54(5):824-44. PubMed ID: 16635664
[TBL] [Abstract][Full Text] [Related]
19. Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life.
Befrits R; Wikman O; Blomquist L; Hjortswang H; Hammarlund P; Bajor A; Klintman D; Blom H
Scand J Gastroenterol; 2013 Sep; 48(9):1027-32. PubMed ID: 23889159
[TBL] [Abstract][Full Text] [Related]
20. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients.
Wells CW; Lewis S; Barton JR; Corbett S
Inflamm Bowel Dis; 2006 Feb; 12(2):123-30. PubMed ID: 16432377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
